BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35842306)

  • 1. Cancer associated autoantibodies in idiopathic inflammatory myopathies: A retrospective cohort from a single center in China.
    Zhao Y; Su H; Yin X; Hou H; Wang Y; Xu Y; Li X; Zhang N; Sun W; Wei W
    Med Clin (Barc); 2023 Jan; 160(1):10-16. PubMed ID: 35842306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
    Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
    Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis Autoantibody Profiles and Clinical Significance in Patients with Inflammatory Myopathies in Southwest China.
    Zhu H; Zhou W; Zheng L; Jiang Y; Lao Y; Li S; Jin M; Wang J; Li X
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy.
    Izuka S; Komai T; Shoda H; Fujio K
    Rheumatol Int; 2023 Feb; 43(2):335-343. PubMed ID: 36175662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort.
    Zhao L; Huang W; Wang H; Chen J; Zhang D; Wang X; Sun F; Ye S
    Int J Rheum Dis; 2023 Jan; 26(1):51-59. PubMed ID: 36117395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
    Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W
    Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narrative review of autoantibodies in idiopathic inflammatory myopathies.
    Liu Y; Zheng Y; Hao H; Yuan Y
    Ann Transl Med; 2023 Apr; 11(7):291. PubMed ID: 37090051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.
    Teel A; Lu J; Park J; Singh N; Basharat P
    Semin Arthritis Rheum; 2022 Dec; 57():152088. PubMed ID: 36116345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What should we expect when two myositis-specific antibodies coexist in a patient.
    Zheng Y; Zhao Y; Hao H; Wang Z; Gao F; Zhang W; Yuan Y
    Eur J Med Res; 2023 Oct; 28(1):429. PubMed ID: 37828570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies.
    Ueda-Hayakawa I; Tonomura K; Maekawa A; Kaneda E; Arase N; Fujimoto M
    J Dermatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 36890683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population.
    Hormaza-Jaramillo A; Bedoya-Joaqui V; Puerta-Sarmiento G; Bautista M; Rios-Serna LJ; Delgado-Mora T; Nieto-Aristizábal I; Ruiz-Ordoñez I
    Front Med (Lausanne); 2022; 9():954937. PubMed ID: 36045923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy.
    Beam MJ; Montgomery A; Anastasiou C; Schmajuk G
    Clin Rheumatol; 2023 Nov; 42(11):3043-3047. PubMed ID: 37542130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center.
    Marklund J; Hanna B; Jin T; Pullerits R
    Front Med (Lausanne); 2024; 11():1340310. PubMed ID: 38606156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients.
    Negalur NV; Ekbote GG; Raval DN; Tanna DV; Kazi WS; Bindroo MA; Yadavalli DJ; Gupta R
    Ann Indian Acad Neurol; 2021; 24(4):552-558. PubMed ID: 34728950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review.
    Kilinc OC; Ugurlu S
    Autoimmun Rev; 2023 Dec; 22(12):103464. PubMed ID: 37863375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
    Sherman MA; Pak K; Pinal-Fernandez I; Flegel WA; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Arthritis Rheumatol; 2023 Sep; 75(9):1668-1677. PubMed ID: 36996276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case in Which Breast Cancer Developed at the Same Time As Dermatomyositis, and the Onset of New Cancer Was Able to Be Predicted by the Exacerbating Skin Symptoms and Parallel Increase in the Anti-TIF1-γ Antibody Levels.
    Akagi H; Wada T
    Intern Med; 2023; 62(20):3057-3062. PubMed ID: 37839875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-depth proteomic analysis of juvenile dermatomyositis serum reveals protein expression associated with muscle-specific autoantibodies.
    Sato H; Inoue Y; Kawashima Y; Konno R; Ohara O; Kuwana M; Kobayashi N; Takezaki S; Akioka S
    Rheumatology (Oxford); 2023 Oct; 62(10):3501-3506. PubMed ID: 37052527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective study on clinical manifestation, thigh MRI and electrophysiology characteristics of immune-mediated necrotizing myopathy].
    Qiao LY; Shi Q; Lin MY; Liu J; Chen ZJ; Pu C
    Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1144-1151. PubMed ID: 36207969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.